It has been reported that the inhibition of BCRP expression effectively reduces ‘stemness’ and chemotherapy resistance in ovarian cancer cells (Januchowski et al., 2016; Jung et al., 2015). The gene discussed is ABCG2; the disease is ovarian carcinoma.